Related Experiment Video
Updated: Nov 15, 2025

03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.1K
Eosinophilic sialodochitis: An emerging atopic condition
Barbara Carey1, Niall O'Neill2, Jackie Brown2
1Oral Medicine, Guy's and St. Thomas Hospital NHS Foundation Trust, London, UK.
Oral Diseases
|March 4, 2021
Summary
Eosinophilic sialodochitis often presents as recurrent salivary gland swelling. This study details the largest cohort, highlighting clinical features and potential allergic links.
Area of Science:
- Otorhinolaryngology
- Allergy and Immunology
- Pathology
Background:
- Eosinophilic sialodochitis is a rare condition affecting salivary glands.
- Understanding its clinical presentation is crucial for diagnosis and management.
Purpose of the Study:
- To describe the clinical characteristics of the largest single-center cohort of patients diagnosed with eosinophilic sialodochitis.
- To identify key demographic, clinical, and laboratory features associated with the condition.
Main Methods:
- Retrospective analysis of 37 patients from a multidisciplinary clinic.
- Collated demographic, clinical, hematological, cytological, histological, and radiological data.
- Assessed patient response to allergy-focused treatments.
Main Results:
- 37 patients (7 male, 30 female) identified, with a mean age of 50.4 years.
- Common symptoms included swelling (97%), itching (92%), discomfort (84%), and "string-like" mucus discharge (76%).
- Atopic disease (62%) and elevated serum IgE (57%) were frequent; eosinophils were present in duct samples (100%) and elevated in peripheral counts (41%).
Conclusions:
- Eosinophilic sialodochitis should be considered in patients with recurrent salivary gland swelling.
- The findings suggest a likely allergic pathogenesis, warranting further investigation into targeted treatments.
Related Concept Videos
Asthma: Pathogenesis and Management
958
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
958
Asthma-II: Pathophysiology and Classification
3.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.6K
Asthma-IV: Diagnostic and Management
2.8K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.5K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Asthma-I: Introduction
3.0K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K
Allergic Reactions
30.0K
Overview
30.0K

